Production of interleukin-10 in human fracture soft-tissue hematomas

Shock

Volumn 6, Issue 1, 1996, Pages 3-6

  Hauser, Carl J ^a,b   Joshi, Pratibha ^a   Zhou, Xinchun ^a   Kregor, Philip ^a   Hardy, Kenneth J ^a   Devidas, Meenakshi ^a   Scott, Paul ^a   Hughes, James L ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; INTERLEUKIN 10; INTERLEUKIN 4; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ARTICLE; BIOSYNTHESIS; BLOOD; BONE SCREW; FEMALE; FEMUR FRACTURE; FRACTURE; HEMATOMA; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; PELVIC GIRDLE; REFERENCE VALUE; RETROSPECTIVE STUDY; TIBIA FRACTURE;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; FEMALE; FEMORAL FRACTURES; FRACTURES, BONE; HEMATOMA; HUMANS; INTERLEUKIN-10; INTERLEUKIN-4; INTERNAL FIXATORS; MALE; MIDDLE AGED; PELVIC BONES; REFERENCE VALUES; RETROSPECTIVE STUDIES; TIBIAL FRACTURES; TRANSFORMING GROWTH FACTOR BETA;

EID: 0030185997     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-199607000-00002     Document Type: Article

References (25)

1. Livingston DH, Mosenthal AC, Deitch EA: Sepsis and multiple organ dysfunction syndrome: A clinical-mechanistic overview. New Horizons 3:257-266, 1995.
2. Ayala A, Ertel W, Chaudry IH: Trauma induced suppression of antigen presentation and expression of major histocompatibility class II antigen complex in leukocytes. Shock 5:79-90, 1996.
3. Howard RJ: Effect of bum injury, mechanical trauma and operation on immune defenses. Surg Clin North Am 59:199-211, 1979.
4. Cheadle WG, Pemberton RM, Robinson D, et al.: Lymphocyte subset responses to trauma and sepsis. J Trauma 35:844-849, 1993.
5. Asadullah K, Woiciechowsky C, Docke W-D, et al.: Immunodepression following neurosurgical procedures. Crit Care Med 23:1976-1983, 1995.
6. O'Sullivan ST, Lederer JA, Horgan AF, et al.: Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. Ann Surg 222:482-492, 1995.
7. Hoch RC, Rodriguez RM, Manning T, et al.: Effects of accidental trauma on cytokine and endotoxin production. Crit Care Med 21:839-845, 1993.
8. Donnelly TJ, Meade P, Jagels M, et al.: Cytokine, complement, and endotoxin profiles associated with the development of the adult respiratory distress syndrome after severe injury. Crit Care Med 22:768-776, 1994.
9. Seibel R, LaDuca J, Hasset JM, et al.: Blunt multiple trauma (ISS 36), femur traction, and the pulmonary failure-septic state. Ann Surg 202:283-295, 1985.
10. Christou NV, MacLean L, Meakins JL: Host defense in blunt trauma. Interrelationships of kinetics of anergy and depressed neutrophil function: Nutritional status and sepsis. J Trauma 20:833-841, 1980.
11. Barbul A, Fishel RS, Shimazu S, et al.: Inhibition of host immunity by fluid and mononuclear cells from healing wounds. Surgery 96:315-319, 1984.
12. Lazarou SA, Barbul A, Wasserkrug HL, Efron G: The wound is a possible source of posttraumatic immunosuppression. Arch Surg 124:1429-1431, 1989.
13. Napolitano LM, Koruda MJ, Meyer AA, Baker CC: The impact of femur fracture with associated soft tissue injury on immune function and intestinal permeability. Shock 1996;5;202-207.
14. Abrams JS, Roncarolo MG, Yssel H, et al.: Strategies of anti-cytokine monoclonal antibody development: Immunoassay of IL-10 and IL-5 in clinical samples. Immunol Rev 127:5-24, 1992.
15. Faist E, Mewes A, Strasser T, et al.: Alteration of monocyte function after major injury. Arch Surg 123:287-292, 1988.
16. Bernhagen J, Calandra T, Mitchell RA, et al.: MIF is a pituitary-derived cytokine that potentiates lethal endotoxemia. Nature 365:756-759, 1993.
17. Calandra T, Bernhagen J, Metz CN, et al.: MIF as a glucocorticoid-induced modulator of cytokine production. Nature 377:68-71, 1995.
18. Moore KW, O'Garra A, de Waal Malefyt R, et al.: Interleukin-10. Annu Rev Immunol 11:165-190, 1993.
19. Roberts AB, Sporn MB: Physiological actions and clinical applications of transforming growth factor-β (TGF-β). Growth Factors 8:1-9, 1993.
20. Marchant A, Deviere J, Baudoin B, et al.: Interleukin-10 production during septicaemia. Lancet 343:707-8, 1994.
21. Sherry RM, Cue JI, Goddard JK, et al.: IL-10 is associated with the development of sepsis in trauma patients. J Trauma 40:613-617, 1996.
22. Chernoff AE, Granowitz EV, Shapiro L, et al.: A phase I study of interleukin-10 in healthy humans: Safety and effects on cytokine production. In deVries JE, de Waal-Malefyt R (eds): Interleukin-10. Austin, TX: R. G. Landes Company, 1995, pp 149-158.
23. de Waal-Malefyt R, Abrams J, Bennett B, et al.: IL-10 inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209-1220, 1991.
24. Fukushima R, Alexandew JW, Gianotti L, et al.: Isolated pulmonary infection acts as a source of systemic tumor necrosis factor, Crit Care Med 22:114-120, 1994.
25. Battafarano RJ, Dunn DL: Contribution of local cytokine production to the systemic host response. Crit Care Med 22:7-8, 1995.